Glycosylated Hemoglobin (HbA1c) as a Marker for Dyslipidemia in Type 2 Diabetes Mellitus

Objective: The purpose of this research was to examine the effectiveness HbA1c as a predictor dyslipidemia in patients with Type-2 Diabetes Mellitus. Study Design: Cross-sectional Place and Duration: Department Pathology; Women Medical & Dental College Abbottabad collaboration Jinnah International Hospital, Abbottabad; April 2022 – September Methods: After obtaining their agreement, total 110 people diabetes mellitus were included research. Statistics background information recorded. Fasting lipid profile (cholesterol, triglycerides, high-density lipoprotein, low-density cholesterol/HDL), HbA1c, creatinine, electrocardiogram conducted part comprehensive systemic examination detect presence complications or co-morbidities. Mean, frequency, correlation analyses are performed SPSS 22.0. When doing analysis, Pearson Chi-square test typically utilized. Results: Twenty-two (20%) had an below 7%, whereas eighty-eight (80%) beyond 7%. Dyslipidemia seen 62 individuals (56.4%). Direct connections found between BMI, cholesterol, lipoprotein (LDL), while inverse (HDL). comparing female male patients, females shown have considerably greater TG levels. levels also significantly correlated metabolic syndrome, particularly among women (P0.003). Conclusion: According findings our research, is not only useful biomarker long-term glycaemic control, but it excellent profile. Keywords: Lipid Profile, Dyslipidemia, Type 2 mellitus,